| Patient | Cleopatra |
|---|---|
| Date of birth | 1997-01-15 |
| Identifiers | MRN HR-AC003-SYN; SSN (made up) 000-03-7095 |
| Document date | 2026-05-12 |
| Author | Nefeli Arvanitis-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Prenatal visit at 19 weeks with the anatomy scans. [S]
Cleopatra returns at 19 weeks 0 days. The nausea stopped about two weeks ago and she has not needed doxylamine with pyridoxine since. She takes aspirin at bedtime without bruising or bleeding, the prenatal vitamin, and ferrous sulfate every other day. She has more energy and has begun to feel movements. She has no bleeding, pain, tightenings, headache, or urinary symptoms. The cell-free DNA result was low risk for trisomies 21, 18, and 13. She had the detailed anatomy scans this morning. [S]
| Element | Detail |
|---|---|
| Nausea | Resolved |
| Screening | Cell-free DNA low risk |
| Fetal movement | First movements felt |
| Medicines | Aspirin, prenatal vitamin, ferrous sulfate every other day |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy better |
| Gastrointestinal | Negative | No nausea, vomiting, or constipation |
| Genitourinary | Negative | No bleeding, leaking fluid, or urinary symptoms |
| Obstetric | Negative | No tightenings or pelvic pressure |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Prenatal vitamin containing folic acid 0.4 mg, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-03 | active | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day | One tablet every other morning with water or orange juice, apart from tea, coffee, and calcium | Oral route | 2026-03-03 | active | S |
| Doxylamine succinate 10 mg / pyridoxine hydrochloride 10 mg delayed-release tablet, two tablets by mouth at bedtime | Two tablets at bedtime; may add one in the morning if needed | Oral route | 2026-03-03 to 2026-05-12 | completed | S |
| Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtime | One tablet by mouth at bedtime from 12 weeks until delivery | Oral route | 2026-03-24 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-12 | Body height | 165 | cm | S |
| 2026-05-12 | Body weight | 61.5 | kg | S |
| 2026-05-12 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 2026-05-12 | Systolic blood pressure | 104 | mm[Hg] | S |
| 2026-05-12 | Diastolic blood pressure | 62 | mm[Hg] | S |
| 2026-05-12 | Heart rate | 88 | /min | S |
| 2026-05-12 | Respiratory rate | 14 | /min | S |
| 2026-05-12 | Body temperature | 36.7 | Cel | S |
| 2026-05-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-12 | Hemoglobin [Mass/volume] in Blood | 11.1 | g/dL | 10.5-15 g/dL | Normal | S |
| 2026-05-12 | Ferritin [Mass/volume] in Serum or Plasma | 24 | ng/mL | 30-150 ng/mL | Low | S |
| 2026-05-12 | Cervix [Length] US | 41 | mm | >=25 mm | Normal | S |
Vital signs recorded on 2026-05-12; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well |
| Abdomen | Fundal height 22 cm, consistent with twins at 19 weeks; non-tender |
| Fetal | Scans: normal anatomy in both twins; fetal hearts 150 and 146 per minute |
| Placenta and cervix | Fused anterior placenta clear of the cervix; transvaginal cervical length 41 mm |
| Urine dipstick | Protein negative |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Uterus larger than dates in early pregnancy: 9 weeks by a certain last menstrual period, with the uterus about 12 to 13 weeks in size; nausea and vomiting heavier than in her first pregnancy; no bleeding; cause not yet known (multiple pregnancy, dating error, fibroids, or molar pregnancy) | resolved | confirmed | O26.841 | S — Synthetic presenting finding anchored to the documented conception in the winter of 41 to 40 BC; it resolves when the ultrasound explains it. |
| Nausea and vomiting of pregnancy, moderate (PUQE score 9); keeping fluids down; no weight loss or ketonuria | resolved | confirmed | O21.9 | S — Synthetic; nausea is common and often heavier in early pregnancy with a large uterus. |
| Iron deficiency anemia in pregnancy: hemoglobin 10.8 g/dL, MCV 79 fL, ferritin 14 ng/mL | active | confirmed | O99.011 | S — Synthetic finding; it echoes no documented diagnosis. |
| Twin pregnancy, dichorionic diamniotic, second pregnancy (gravida 2, para 1): two live fetuses with a thick dividing membrane and a twin-peak (lambda) sign at 11 weeks; dated by her last period, confirmed by the crown-rump lengths | active | confirmed | O30.041 | S — Synthetic modern diagnosis anchored to the documented twins of 40 BC; chorionicity is a modern finding and makes no claim about her real pregnancy. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure and urine protein | Every prenatal visit | Completed today | 104/62 mmHg; urine protein negative |
| Examination | Fetal hearts and fundal height | Every prenatal visit | Completed today | Fetal hearts 150 and 146 per minute; fundal height 22 cm |
| Examination | Weight gain (about 17 to 25 kg for twins from a normal BMI) | Every prenatal visit | Completed today | 61.5 kg, up 3.5 kg since intake |
| Imaging | Detailed anatomy scans with placental location | At 18 to 22 weeks | Completed today | Normal anatomy in both twins; placenta anterior and clear of the cervix |
| Imaging | Cervical length | At the anatomy scan; routine serial screening is not supported in twins | Completed today | 41 mm by transvaginal scan |
| Laboratory | Cell-free DNA screening | From 10 weeks, as she chose | Completed today | Low risk for trisomies 21, 18, and 13 |
| Laboratory | Hemoglobin and ferritin | At intake, at the anatomy-scan visit, at 24 to 28 weeks, and in the third trimester | Completed today | Hemoglobin 11.1 g/dL and ferritin 24 ng/mL; responding to oral iron |
| Medication safety | Low-dose aspirin | Daily from 12 weeks until delivery; review at every visit | Completed today | Taken nightly since 12 weeks; no bruising or bleeding |
| Imaging | Growth scan with discordance | Every four weeks from about 20 to 24 weeks in a dichorionic twin pregnancy | Due | First growth scan booked at 25 weeks |
| Laboratory | Gestational diabetes screen | At 24 to 28 weeks | Due | At 25 weeks |
| Survey | Perinatal mood screen (EPDS) | Each trimester | Due | Second-trimester screen at 25 weeks |
| Self-management | Preterm labor warning signs | Every prenatal visit | Completed today | Warning signs reviewed |
Goal progress:
Guideline basis: Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231 (2021); Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234 (2021); Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020); Anemia in Pregnancy: ACOG Practice Bulletin, Number 233 (2021); Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021)
Follow-up: Prenatal visit with the growth scan, blood count, and glucose challenge at 25 weeks. Next scheduled visit 2026-06-23: prenatal visit at 25 weeks: growth scan, glucose challenge, and blood count. [S]